Abstract
Comorbidities may affect survival and choice of treatment among cancer patients. In fact, comorbidities have been identified as significant determinants of response to therapy in older patients with acute myeloid leukemia, breast cancer, head and neck cancer, and lung cancer. The Charlson comorbidity index and adult comorbidity evaluation-27 are lists of comorbidities with a weight assigned from 1 to 6 for the former and from 0 to 3 for the latter score, derived from relative risk estimates of a proportional hazard regression model using clinical data.
Lingua originale | Inglese |
---|---|
pagine (da-a) | 1457-1461 |
Numero di pagine | 5 |
Rivista | Haematologica |
Volume | 96 |
Numero di pubblicazione | 10 |
DOI | |
Stato di pubblicazione | Pubblicato - 2011 |
All Science Journal Classification (ASJC) codes
- Ematologia
Keywords
- Aged
- Antineoplastic Agents
- BCR-ABL Positive
- Chronic
- Female
- Humans
- Incidence
- Leukemia
- Male
- Medication Adherence
- Myelogenous
- Pleural Effusion
- Protein Kinase Inhibitors
- Pyrimidines
- Retrospective Studies
- Thiazoles
- Treatment Outcome